CytoMed Therapeutics (GDTC) Loans - Net (2021 - 2022)
CytoMed Therapeutics' (GDTC) quarterly Loans - Net came in at $3.4 million in Q4 2022, up 47.19% year-over-year from $2.3 million in Q4 2021, and up 47.19% quarter-over-quarter from $2.3 million in Q4 2021.
Powered by 
Analysis
CytoMed Therapeutics (GDTC) Loans - Net (2021 - 2022) Analysis & Trends
CytoMed Therapeutics has disclosed Loans - Net across 2 years of filings, most recently posting $3.4 million for Q4 2022.
- In Q4 2022, Loans - Net rose 47.19% year-over-year to $3.4 million; the TTM figure through Dec 2022 stood at $3.4 million (up 47.19% YoY), while the FY2022 annual figure was $3.4 million, up 47.19% from the prior year.
- Loans - Net came in at $3.4 million for Q4 2022 at CytoMed Therapeutics, up from $2.3 million in the prior quarter.
- In the past five years, Loans - Net ranged from a high of $3.4 million in Q4 2022 to a low of $2.3 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.20 Bn | 9.36 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.35 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.56 Bn | 2.59 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.17 Bn | 1.37 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.76 Bn | 56.40 Mn | - |
| 10 | CytoMed Therapeutics | 9.34 Mn | 7.72 Mn | - | - |